Gao, Jianjun http://orcid.org/0000-0001-6138-4472
Navai, Neema
Alhalabi, Omar http://orcid.org/0000-0002-9658-2206
Siefker-Radtke, Arlene
Campbell, Matthew T. http://orcid.org/0000-0003-1915-4491
Tidwell, Rebecca Slack http://orcid.org/0000-0003-3041-8582
Guo, Charles C.
Kamat, Ashish M.
Matin, Surena F.
Araujo, John C.
Shah, Amishi Y.
Msaouel, Pavlos
Corn, Paul
Wang, Jianbo
Papadopoulos, John N.
Yadav, Shalini S.
Blando, Jorge M.
Duan, Fei
Basu, Sreyashi http://orcid.org/0000-0002-5028-3833
Liu, Wenbin
Shen, Yu http://orcid.org/0000-0002-3899-7868
Zhang, Yuwei
Macaluso, Marc Daniel
Wang, Ying
Chen, Jianfeng
Zhang, Jianhua http://orcid.org/0000-0001-5412-9860
Futreal, Andrew http://orcid.org/0000-0001-8663-2671
Dinney, Colin
Allison, James P.
Goswami, Sangeeta
Sharma, Padmanee http://orcid.org/0000-0003-4658-055X
Article History
Received: 13 April 2020
Accepted: 28 August 2020
First Online: 12 October 2020
Competing interests
: J.G. served as a consultant on a scientific advisory board for AstraZeneca and received compensation as an advisor. A.M.K. served on a scientific advisory board for AstraZeneca and received compensation as an advisor. A.S.-R. is on a scientific advisory board for AstraZeneca and receives compensation as an advisor. J.B. became an AstraZeneca employee after the work on this manuscript was completed. P.S. and J.P.A. do not have any competing interest with this manuscript. However, they provided a list of all disclosures for transparency. P.S. has ownership in Jounce, BioNTx, Constellation, Oncolytics, BioAtla, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Codiak, ImaginAb, Dragonfly, Lytix, Lava Therapeutics, Infinity Pharma, Adaptive Biotechnologies and Hummingbird. J.P.A. has ownership in Jounce, BioNTx, BioAtla, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Adaptive Biotechnologies and Codiak. P.S. serves as a consultant for Constellation, Jounce, Kite Pharma, Neon, BioAtla, Oncolytics Biotech, Forty-Seven, Polaris, Apricity, Marker Therapeutics, Codiak, ImaginAb, Dragonfly, Lava Therapeutics, Infinity Pharma, Lytix and Hummingbird. J.P.A. serves as a consultant for Jounce, Neon, Forty-Seven, Apricity, Polaris, Marker Therapeutics, Codiak, ImaginAb, Lava Therapeutics, Dragonfly, Lytix and Hummingbird. J.G. serves as a consultant for ARMO Biosciences, CRISPR Therapeutics, Jounce, Nektar, Pfizer, Polaris and Symphogen.